Treatment
Comparator clinical trials
We’re tracking 1,699 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT06519266RecruitingPhase 3
Liver treatment with immunotherapy for uveal melanoma that spread to the liver
This trial tests whether adding a liver-directed therapy (PHP) to a combination of two immunotherapy drugs (ipilimumab and nivolumab) works better than the immunotherapy drugs alone for people whose uveal melanoma has spread to the liver.
GothenburgAges 18 years+ - NCT07614672Enrolling by invitation
Instrument-Assisted vs. Manual Massage for Heel Pain
This study compares two hands-on treatment techniques for plantar fasciitis—a common cause of heel pain. Researchers want to see which approach works better to reduce pain and improve how you walk.
Islamabad, FederalAges 19–64 - NCT07619118RecruitingPhase 3
Laroprovstat and rosuvastatin vs. rosuvastatin for high cholesterol
This trial tests whether adding a new medicine, laroprovstat, to a standard cholesterol drug (rosuvastatin) is better at lowering bad cholesterol than the standard drug alone. It might help people who are at high risk for heart disease or stroke.
Sun City West, ArizonaAges 18–130 - NCT07619131RecruitingPhase 3
New cholesterol-lowering combination pill for at-risk adults
This study tests a new combination pill containing two cholesterol-lowering medications (laroprovstat and rosuvastatin) in people who have never taken cholesterol medicine before. The goal is to see if the combination works better than either medicine alone at lowering LDL cholesterol, which is the 'bad' cholesterol that can increase heart disease risk.
Dothan, AlabamaAges 18–130 - NCT07615868RecruitingPhase 1
New blood-thinner study for heart disease patients in China
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
BeijingAges 18–85 - NCT06707246Recruiting
Comparing secukinumab and tofacitinib for hidradenitis suppurativa
This trial tests two medications, secukinumab and tofacitinib, to see which works better for moderate to severe hidradenitis suppurativa (a skin condition causing painful bumps) in Chinese patients. The goal is to find a more effective treatment option.
Hangzhou, ZhejiangAges 18–75 - NCT06681688RecruitingPhase 1/Phase 2
Comparing two approaches to prevent cataract surgery complications
This study compares two ways to prevent complications after cataract surgery. One group gets a special combination of eye drops and a steroid injection before surgery, and the other group gets standard care. The goal is to see which approach leads to fewer problems after surgery.
Venice, FloridaAges 18 years+ - NCT07611110RecruitingPhase 3
AZD2265 vs standard care for advanced prostate cancer
This trial tests a new cancer-fighting drug called AZD2265 against standard treatment for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. You may qualify if your cancer previously responded to PSMA-targeted radiation treatments but is now growing again.
Dothan, AlabamaAges 18 years+ - NCT07604766RecruitingPhase 3
Rina-S for platinum-resistant ovarian cancer in China
This study tests a new cancer drug called Rina-S (an antibody-drug conjugate, which is a targeted therapy that delivers medicine directly to cancer cells) compared to standard treatment options for ovarian cancer that has returned or worsened after platinum chemotherapy. The trial is specifically for patients in China whose cancer is resistant to platinum drugs.
ChangchunAges 18 years+ - NCT07604181Recruiting
Telerehabilitation vs clinic therapy for stroke arm recovery
This trial compares two ways of helping stroke survivors regain arm and hand function: therapy done remotely online versus in-person at a clinic. Both use a specialized approach called constraint-induced movement therapy, which encourages use of the weaker arm. The study aims to see which method works better for people in the first 6 months after stroke.
Faisalabad, Punjab ProvinceAges 40–70 - NCT07608874Recruiting
Comparing stitching techniques to reduce scar problems after first cesarean
This trial compares two ways of closing the uterus during a planned cesarean section to see which creates a stronger scar and prevents complications. If you're having your first cesarean delivery, this research may help doctors improve the procedure.
Baden, Canton of AargauAges 18 years+ - NCT07604376Recruiting
Nerve Block Pain Relief After Cesarean Delivery
This study tests whether a nerve-numbing injection in the abdomen helps reduce pain after a cesarean (C-section) delivery. The injection uses a local anesthetic to numb the area around your surgical wound, potentially reducing pain and the need for stronger pain medicines after surgery.
Târgu Mureş, Mureș CountyAges 18 years+ - NCT07608614Recruiting
How sleep affects thinking and performance
This study looks at how sleep influences your thinking, memory, and ability to perform tasks. Researchers will use brain imaging (MRI) and sleep monitoring to understand these connections, which could help improve sleep and performance in the future.
Seattle, WashingtonAges 18–30 - NCT07604506Enrolling by invitation
Ultrasound nerve block training for junior emergency doctors
This study teaches junior doctors in emergency medicine how to use ultrasound to safely perform nerve blocks—a pain-relief technique. Researchers will compare learning with a low-cost practice model to see if it works as well as expensive alternatives.
Kubang Kerian, KelantanAges Any age - NCT06711120Recruiting
Comparing two treatments for varicose veins in the lower legs
This study compares two minimally invasive treatments (radiofrequency ablation and microwave ablation) for varicose veins in the small saphenous vein. If your varicose veins cause symptoms like pain, swelling, or heaviness, this trial may help determine which treatment works better.
ChengduAges 18–90 - NCT06211712Recruiting
Drug plus clot removal for large vessel stroke
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
ShanghaiAges 18 years+ - NCT06573008RecruitingPhase 3
Testing GP681 Tablets for Flu in High-Risk Patients
This study tests an oral tablet called GP681 for people with flu who are at higher risk of serious complications. It compares the new drug to a placebo to see if it helps reduce symptoms faster.
ChizhouAges 12 years+ - NCT07598708RecruitingPhase 2/Phase 3
Cleminorexton for Narcolepsy: A New Treatment Study
This study tests whether a new medication called cleminorexton helps people with narcolepsy (a condition causing severe daytime sleepiness) sleep better and feel more alert. You would take this medication instead of your current narcolepsy drugs for several months to see if it works.
Birmingham, AlabamaAges 18–70 - NCT07597018RecruitingPhase 1
Comparing Blood Levels of Cagrilintide Versions in Adults With Overweight
This early-stage study tests different formulations of cagrilintide, a new medication, to see how the body absorbs and processes each version. Cagrilintide may help with weight management. Researchers will measure blood levels after you receive multiple doses.
BerlinAges 18–64 - NCT07595276RecruitingPhase 3
Comparing two EGFR antibody treatments for colorectal cancer
This trial tests a new antibody drug against a standard one, both combined with chemotherapy, for advanced colorectal cancer that has not spread before. It aims to see which is safer and more effective.
GuangzhouAges 18 years+ - NCT07600268RecruitingPhase 2
Radiation plus maintenance drugs for advanced pancreatic cancer
This trial tests whether adding a focused radiation treatment (SBRT) to ongoing chemotherapy drugs works better than the drugs alone for pancreatic cancer that has stabilized or shrunk after initial treatment. The goal is to see if this combination approach helps patients live longer.
Jinan, ShandongAges 18–70 - NCT07598487Enrolling by invitation
Physical Therapy Techniques for Stroke Recovery and Balance
This study compares two types of physical therapy to help people regain trunk control and balance after a stroke. Participants will receive either PNF (a hands-on technique using rhythmic movements) or NDT (another hands-on technique focusing on movement patterns) to improve stability.
Faisalabad, Punjab ProvinceAges 40–65 - NCT07600359Recruiting
Physical therapy techniques for sacroiliac joint pain
This study compares two hands-on physical therapy techniques to reduce lower back pain, improve walking, and restore function in people with sacroiliac joint dysfunction (a condition affecting the joint connecting your spine to your pelvis). You'll receive treatment and be assessed to see which technique works better.
Islamabad, Punjab ProvinceAges 25–45 - NCT07595783Recruiting
Brain Training for Children With ADHD Using Neurofeedback
This study tests a new type of brain training called neurofeedback to help children with ADHD. Children complete sessions where they learn to control their own brain activity, which may improve attention and focus.
BielefeldAges 6–13
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,699 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.